August, 2023

article thumbnail

Pharmacy Staffing Shortages Lead to Disruptions in Patient Care

Drug Topics

A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.

article thumbnail

Opioid Settlement May Spur Cannabis as Potential New Pharmacy Revenue Stream

Pharmacy Times

The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.

169
169
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

STAT

WOODBURY, Minn. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages. The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. Teske told her boss at the vascular clinic where she worked that she was pregnant, and he asked if she wanted to sneak a look using the clinic’s ultrasound.

article thumbnail

Amid shortage, FDA clears several generics of Takeda's popular ADHD drug Vyvanse

Fierce Pharma

After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.

FDA 138
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Info blocking enforcement for health IT entities begins Sept. 1, brings fines of up to $1M per violation

Fierce Healthcare

Enforcement of information blocking penalties for health IT entities is slated to go into effect on Friday, opening the door to penalties of up to $1 million per violation. | The Department of Health and Human Services Office of Inspector General said it expects to receive more complaints than it can investigate and so will be prioritizing those meeting certain criteria.

135
135
article thumbnail

Stem cell therapy delivers potential for sickle cell disease

European Pharmaceutical Review

New research published in the New England Journal of Medicine has indicated that stem cell gene therapy could provide a curative treatment for sickle cell disease (SCD). Based on new data from the Novartis Phase I/II clinical trial , which used the first therapy to target a new genetic area and use cryopreserved stem cells, trial participants reported a decrease in vaso-occlusive events.

Hospitals 111

More Trending

article thumbnail

Revolutionizing Drug Development Through Artificial Intelligence, Machine Learning

Pharmacy Times

The seamless integration of artificial intelligence and machine learning has the potential to accelerate research and enhance efficiency in a new era of personalized medicine.

169
169
article thumbnail

STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

STAT

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process. The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.

article thumbnail

Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower

Fierce Pharma

Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond the separation of its consumer health unit—Chief Financial Officer Joe Wolk described the compan | Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond separation of its consumer health unit—Chief Financial Officer Joe Wolk described the company’s appetite for M&A as “voracious.

130
130
article thumbnail

Humana launches in-home primary care through CenterWell

Fierce Healthcare

Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.

134
134
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Stetson and Luke Grimes saddle up to reignite the brand for the modern age

Drug Store News

In our Q&A with Stephen Mormoris, CEO of Scent Beauty, he shares how teaming up with Yellowstone star Luke Grimes is helping the fragrance reach a younger audience.

111
111
article thumbnail

Evaluating Pharmacist-Driven CGM Services in Community, Ambulatory Care Settings

Drug Topics

A recent study found that there was a lack of strong evidence supporting the use of continuous glucose monitor programs in community pharmacies.

article thumbnail

FDA Approves 0.9% Sodium Chloride Injection in 10, 20 mL Single-Dose Vials

Pharmacy Times

Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.

FDA 149
article thumbnail

Medicaid rebukes states for mistakenly disenrolling children

STAT

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.

Insurance 143
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA turns down Outlook's ophthalmic version of Roche's Avastin over manufacturing, data shortfalls

Fierce Pharma

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. | Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated version, but instead got a rejection letter.

FDA 126
article thumbnail

CMS suspects auto-renewal process at fault for wrongful Medicaid disenrollments

Fierce Healthcare

In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.

132
132
article thumbnail

Watch DSN: The Compliance Team touches on clinical services’ effect on pharmacy space

Drug Store News

At NACDS’ Total Store Expo, DSN caught up with The Compliance Team’s founder and CEO to discuss how clinical services are changing the retail pharmacy space.

116
116
article thumbnail

Filling Prescriptions for Pet Patients: Best Practices

Drug Topics

Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.

187
187
article thumbnail

Ferric Carboxymaltose Therapy Does Not Significantly Improve Heart Failure Mortality

Pharmacy Times

Ferric carboxymaltose was not found to have a significant impact on 6-minute walk distance, which is part of the primary outcome’s hierarchical composite of death and hospitalizations from heart failure.

Hospitals 145
article thumbnail

STAT+: Departing Stanford president retracts two widely cited papers, against lead author’s wishes

STAT

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne , the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

141
141
article thumbnail

Johnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections

Fierce Pharma

Seven weeks after saying it would allow generic competition for drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low- and middle-income countries (LMICs), Johnson & Johnson h | Seven weeks after saying it would allow generic competition for drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low- and middle-income countries (LMICs), Johnson & Johnson has slashed its own drug's price by 55% to $130 for a six-month course.

118
118
article thumbnail

Providers can now see patients' insurance coverage in GoodRx's cost comparison tool

Fierce Healthcare

GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.

article thumbnail

Hallmark, Venmo join forces on secure money card gifting experience

Drug Store News

The Hallmark + Venmo cards aim to make it possible for customers to give a physical card with money through Venmo by removing the worry of lost cash or checks, the companies said.

105
105
article thumbnail

Moderna, Novavax Update Vaccines as COVID-19 Variants Cause Rise in Cases

Drug Topics

The CDC and WHO are currently tracking several variants that are driving the majority of new cases around the world.

Vaccines 187
article thumbnail

Transforming Medication Safety into a Value-Driver

Pharmacy Times

Advanced technology can automate many pharmacovigilance tasks to build workflow efficiencies, reduce manual intervention, and free up team members for more strategic activities.

123
123
article thumbnail

Opinion: It’s long past time for a more comprehensive Covid treatment approach

STAT

Because Covid cases and hospitalizations are no longer front-page news, many Americans might be surprised to learn that we are in the midst of a mini-surge. The latest data from the Centers for Disease Control and Prevention, from Aug. 12, confirm a 21.6% increase in Covid-19 hospitalizations from the prior week and a 21.4% increase in Covid-related deaths, demonstrating that Covid is not over and that Latinos and Blacks have reason to be concerned.

Hospitals 136
article thumbnail

Catalent passes baton to activist investor Elliott after 2023 earnings disappoint

Fierce Pharma

After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is handing the reins to activist investor Elliott Management. | After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is linking up with Elliott Management. The CDMO giant struck a cooperation agreement with the activist investor group as it announced fourth-quarter revenues and unveiled a sweeping governance shakeup.

115
115
article thumbnail

How behavioral health app BeMe is aiming to connect with teens

Fierce Healthcare

In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.

129
129
article thumbnail

Huggies, Walgreens raise awareness of U.S. families struggling with diaper need

Drug Store News

For every pack of Huggies Diapers purchased at Walgreens through September, Huggies will donate a day’s worth of diapers to the National Diaper Bank Network, up to one million diapers.

105
105
article thumbnail

Don’t Get Caught Up With a HIPAA Violation

Drug Topics

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

HIPAA 200
article thumbnail

CDC Recommends Beyfortus for Routine Use to Protect Infants, Young Children Against Respiratory Syncytial Virus

Pharmacy Times

Nirsevimab (Beyfortus) is the first respiratory syncytial virus (RSV) preventative drug to be approved by the FDA, and can protect infants through their first RSV season for up to 5 months.

FDA 123
article thumbnail

A big insurer decides to cover naloxone for overdose; will others follow?

STAT

At long last, naloxone is available over the counter.  But now comes a moment of truth for the overdose-reversal medication: Will increased access help to save lives? And more immediately, can everyone who wants to buy naloxone at a pharmacy afford it?

Insurance 134
article thumbnail

Sanofi shakes up leadership as specialty care head Sibold departs to pursue outside opportunity

Fierce Pharma

For six years, Sanofi's specialty care chief Bill Sibold has helped the company make the most of its Regeneron-partnered immunology superstar Dupixent. | Bill Sibold, who took over the company's specialty care unit in 2017 just after Dupixent's first approval, is leaving Sanofi effective immediately. The company further shook up its leadership by appointing a new R&D head, a chief digital officer and adding an entirely new position.

114
114
article thumbnail

Headspace, Intermountain's Castell team up to expand behavioral health access

Fierce Healthcare

Digital mental health company Headspace is teaming up with Castell, Intermountain Healthcare’s value-based care subsidiary, to expand access to virtual mental health services. | The partnership will provide members of select insurance plans in Utah access to Headspace’s self-guided content, behavioral health coaching and therapy in an outcomes-based payment model.

Insurance 121